Jeffrey Dierks is CHIEF COMMERCIAL OFFICER of Harmony Biosciences Holdings, Inc.. Currently has a direct ownership of 0 shares of HRMY, which is worth approximately $0. The most recent transaction as insider was on Feb 17, 2022, when has been sold 4,259 shares (Common Stock) at a price of $40.02 per share, resulting in proceeds of $170,445. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jeffrey Dierks Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2022
SELL
Open market or private sale
$170,445 $40.02 p/Share
4,259 Reduced 100.0%
0 Common Stock
Feb 17 2022
BUY
Exercise of conversion of derivative security
$4,800 $24.0 p/Share
200 Added 50.0%
200 Common Stock
Feb 16 2022
SELL
Open market or private sale
$170,573 $40.05 p/Share
4,259 Reduced 100.0%
0 Common Stock
Feb 16 2022
BUY
Exercise of conversion of derivative security
$102,216 $24.0 p/Share
4,259 Added 50.0%
4,259 Common Stock
Jan 06 2022
SELL
Open market or private sale
$247,756 $40.45 p/Share
6,125 Reduced 100.0%
0 Common Stock
Jan 06 2022
BUY
Exercise of conversion of derivative security
$50,348 $8.22 p/Share
6,125 Added 50.0%
6,125 Common Stock
Nov 01 2021
SELL
Open market or private sale
$419,000 $41.9 p/Share
10,000 Reduced 100.0%
0 Common Stock
Nov 01 2021
BUY
Exercise of conversion of derivative security
$82,200 $8.22 p/Share
10,000 Added 50.0%
10,000 Common Stock
Sep 07 2021
SELL
Open market or private sale
$185,000 $37.0 p/Share
5,000 Reduced 100.0%
0 Common Stock
Sep 07 2021
BUY
Exercise of conversion of derivative security
$41,100 $8.22 p/Share
5,000 Added 50.0%
5,000 Common Stock
Sep 01 2021
SELL
Open market or private sale
$337,800 $33.78 p/Share
10,000 Reduced 100.0%
0 Common Stock
Sep 01 2021
BUY
Exercise of conversion of derivative security
$82,200 $8.22 p/Share
10,000 Added 50.0%
10,000 Common Stock
Aug 27 2021
SELL
Open market or private sale
$119,612 $35.18 p/Share
3,400 Reduced 100.0%
0 Common Stock
Aug 27 2021
BUY
Exercise of conversion of derivative security
$27,948 $8.22 p/Share
3,400 Added 50.0%
3,400 Common Stock
Aug 26 2021
SELL
Open market or private sale
$56,016 $35.01 p/Share
1,600 Reduced 100.0%
0 Common Stock
Aug 26 2021
BUY
Exercise of conversion of derivative security
$13,152 $8.22 p/Share
1,600 Added 50.0%
1,600 Common Stock
Jun 15 2021
SELL
Open market or private sale
$469,800 $31.32 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jun 15 2021
BUY
Exercise of conversion of derivative security
$123,300 $8.22 p/Share
15,000 Added 50.0%
15,000 Common Stock
JD

Jeffrey Dierks

CHIEF COMMERCIAL OFFICER
Plymouth Meeting, PA

Track Institutional and Insider Activities on HRMY

Follow Harmony Biosciences Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRMY shares.

Notify only if

Insider Trading

Get notified when an Harmony Biosciences Holdings, Inc. insider buys or sells HRMY shares.

Notify only if

News

Receive news related to Harmony Biosciences Holdings, Inc.

Track Activities on HRMY